Potential Usefulness of IgA for the Early Detection of SARS-CoV-2 Infection: Comparison With IgM
20 giu 2024
INFORMAZIONI SU QUESTO ARTICOLO
Categoria dell'articolo: Minireview
Pubblicato online: 20 giu 2024
Pagine: 123 - 130
Ricevuto: 29 feb 2024
Accettato: 22 apr 2024
DOI: https://doi.org/10.33073/pjm-2024-019
Parole chiave
© 2024 Pei Wang, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Fig. 1.

Positive detection rate for IgA and IgM at an early stage of SARS-CoV-2 infection_
IgA | IgM | Time point | Target antigen | Principles | References | ||
---|---|---|---|---|---|---|---|
IgA | IgM | IgA | IgM | ||||
100% | 0% | 5–7 days | S1 | N + S | ELISA | CLIA | |
92.7% | 85.4% | 1–7 days | N | N | ELISA | ELISA | |
31.3% | 14.6% | 1–7 days | RBD | RBD | PRI | PRI | |
23.0% | 2.1% | 1–7 days | N | N | PRI | PRI | |
60.0% | 53.3% | 1–7 days | N | N | ELISA | ELISA | |
28.0% | 10% | 1–7 days | N/S | N/S | CMIA | CMIA | Pisanic et al. 2021 |
50.0% |
0% |
1–7 days | N/S | N/S | CMIA | CMIA | Pisanic et al. 2021 |